Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T12:45:15.506Z.
Calculation as of: 2026-10-06T12:45:15.506Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fa223cd5a0006a47bd3f11d3634c651a1c818c2f8beb58cb941cded2cdd6eca8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Adial Pharmaceuticals, Inc.
Market Cap
$11.42M
EBITDA Yield
N/A
| NAME | MARKET CAP | EBITDA YIELD |
|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.42M | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.41M | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
